3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Acute malaria: new trials by email Literature Review of Acute malaria trials Research Report on Acute malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1) M5717 330 mg, M5717 500 mg, M5717 660 mg - Acute Malaria | Phase 2 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 38 | 2023-03-29 | 2025-08-27 |
| Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection KAF156 - Malaria | Phase 2 | Completed | Novartis Pharmaceuticals | 43 | 2013-03-01 | 2018-06-07 |
| Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection KAE609 - Malaria | Phase 2 | Completed | Novartis Pharmaceuticals | 27 | 2012-01-01 | 2013-05-13 |
Malaria (2) · Malaria, Falciparum (1)
Infections (3) · Mosquito-Borne Diseases (3) · Parasitic Diseases (3) · Protozoan Infections (3) · Vector Borne Diseases (3) · Malaria (1)
NITD 609 (1) · ganaplacide (1) · pyronaridine (1)
Novartis Pharmaceuticals (2) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)
Thailand (2) · Burkina Faso (1) · Gabon (1) · Mozambique (1) · Uganda (1) · Vietnam (1)